441 related articles for article (PubMed ID: 11504768)
41. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
42. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
43. Retinoic acid via RARalpha inhibits the expression of 24-hydroxylase in human prostate stromal cells.
Lou YR; Miettinen S; Kagechika H; Gronemeyer H; Tuohimaa P
Biochem Biophys Res Commun; 2005 Dec; 338(4):1973-81. PubMed ID: 16289102
[TBL] [Abstract][Full Text] [Related]
44. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression.
Clark CS; Konyer JE; Meckling KA
Exp Cell Res; 2004 Mar; 294(1):301-11. PubMed ID: 14980523
[TBL] [Abstract][Full Text] [Related]
45. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
46. Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions.
Thompson PD; Jurutka PW; Haussler CA; Whitfield GK; Haussler MR
J Biol Chem; 1998 Apr; 273(14):8483-91. PubMed ID: 9525962
[TBL] [Abstract][Full Text] [Related]
47. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
[TBL] [Abstract][Full Text] [Related]
49. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
50. Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas.
Ng KY; Ma MT; Leung KK; Leung PS
Stem Cell Rev Rep; 2011 Mar; 7(1):53-63. PubMed ID: 20354914
[TBL] [Abstract][Full Text] [Related]
51. Monocytic differentiation of acute promyelocytic leukemia cells in response to 1,25-dihydroxyvitamin D3 is independent of nuclear receptor binding.
Bhatia M; Kirkland JB; Meckling-Gill KA
J Biol Chem; 1995 Jul; 270(27):15962-5. PubMed ID: 7608152
[TBL] [Abstract][Full Text] [Related]
52. Auranofin promotes retinoic acid- or dihydroxyvitamin D3-mediated cell differentiation of promyelocytic leukaemia cells by increasing histone acetylation.
Park SJ; Kim M; Kim NH; Oh MK; Cho JK; Jin JY; Kim IS
Br J Pharmacol; 2008 Jul; 154(6):1196-205. PubMed ID: 18500361
[TBL] [Abstract][Full Text] [Related]
53. Cooperation between antioxidants and 1,25-dihydroxyvitamin D3 in induction of leukemia HL60 cell differentiation through the JNK/AP-1/Egr-1 pathway.
Wang Q; Salman H; Danilenko M; Studzinski GP
J Cell Physiol; 2005 Sep; 204(3):964-74. PubMed ID: 15799027
[TBL] [Abstract][Full Text] [Related]
54. Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells.
Wang X; Studzinski GP
J Cell Biochem; 2001; 80(4):471-82. PubMed ID: 11169731
[TBL] [Abstract][Full Text] [Related]
55. Cell cycle arrest and apoptosis induced by 1α,25(OH)2D3 and TX 527 in Kaposi sarcoma is VDR dependent.
González-Pardo V; Suares A; Verstuyf A; De Clercq P; Boland R; de Boland AR
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():197-200. PubMed ID: 24316429
[TBL] [Abstract][Full Text] [Related]
56. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
[TBL] [Abstract][Full Text] [Related]
57. 1 alpha,25-dihydroxyvitamin D3 transrepresses retinoic acid transcriptional activity via vitamin D receptor in myeloid cells.
Bastie JN; Balitrand N; Guidez F; Guillemot I; Larghero J; Calabresse C; Chomienne C; Delva L
Mol Endocrinol; 2004 Nov; 18(11):2685-99. PubMed ID: 15284334
[TBL] [Abstract][Full Text] [Related]
58. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones.
Taoka T; Collins ED; Irino S; Norman AW
Mol Cell Endocrinol; 1993 Sep; 95(1-2):51-7. PubMed ID: 8243807
[TBL] [Abstract][Full Text] [Related]
59. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH
Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820
[TBL] [Abstract][Full Text] [Related]
60. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
Kong J; Li YC
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E916-24. PubMed ID: 16368784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
